Switzerland: Novocure secures non-dilutive funding from Pharmakon
Nasdaq-listed, Root-headquartered global oncology company, Novocure, has entered into a new five-year senior secured credit facility of up to US$400m with funds managed by...
The Netherlands: Vitrolife acquires eFertility
Vitrolife, a Sweden-based global provider of reproductive health, is acquiring 100% of the shares in eFertility (STB Zorg), a software solution for fertility clinics...
Austria: Fresenius divests Vamed’s rehabilitation business to PAI Partners
Global healthcare group, Fresenius, has reached an agreement with France-based private equity investor, PAI Partners, for the sale of the majority of Vamed’s rehabilitation...
UK: Limerston Capital backed Cormica underlines global ambitions with first acquisition into US
UK-based medical device and pharmaceuticals testing group, Cormica (formerly known as WMP Group), has completed the seven-figure purchase of TPM Laboratories, an independent contract...
Ireland: Icon prices US$2bn three-part bond offering
Dublin-headquartered Icon, a Nasdaq-listed global CRO, has priced a US$2bn SEC-registered bond offering, consisting of US$750m 5.809% senior secured notes due 2027, US$750m 5.849%...
The Netherlands: European LifeCare strengthens position with acquisition of PreventVaccins
Inflexion portfolio company, European LifeCare Group (ELCG), Europe’s largest independent provider of travel clinics and vaccinations, has acquired PreventVaccins, a Netherlands based provider of vaccinations...
Italy: Donaldson enters agreement to acquire minority stake in Medica
Donaldson Company, a New York-listed provider of filtration products and solutions, has agreed to purchase a 49% stake via tender offer in Italy-based Medica....
Germany: Greenpeak Partners closes Continuation Fund led by HarbourVest Partners
Greenpeak Partners, a lower mid-market focused buy and build specialist in the DACH region, has closed its Greenpeak Continuation Fund I with total commitments...
France: Esteve Healthcare acquires Perrigo’s HRA Pharma Rare Diseases business
Esteve Healthcare, a Barcelona-headquartered global pharmaceutical company, is acquiring Perrigo’s HRA Pharma Rare Diseases business for up to €275m (US$296m), consisting of an upfront...
The Netherlands: KKR buys nexeye from 3i
KKR has acquired Gorinchem-headquartered nexeye from investment firm 3i Group.
nexeye is a European provider of value-for- money eye care operating under the Hans Anders,...
Advertisement
